189 related articles for article (PubMed ID: 33044406)
1. The value of skeletal standardized uptake values obtained by quantitative single-photon emission computed tomography-computed tomography in differential diagnosis of bone metastases.
Zhang Y; Li B; Yu H; Song J; Zhou Y; Shi H
Nucl Med Commun; 2021 Jan; 42(1):63-67. PubMed ID: 33044406
[TBL] [Abstract][Full Text] [Related]
2. Maximum standardized uptake value from quantitative bone single-photon emission computed tomography/computed tomography in differentiating metastatic and degenerative joint disease of the spine in prostate cancer patients.
Mohd Rohani MF; Mat Nawi N; Shamim SE; Wan Sohaimi WF; Wan Zainon WMN; Musarudin M; Said MA; Hashim H
Ann Nucl Med; 2020 Jan; 34(1):39-48. PubMed ID: 31612417
[TBL] [Abstract][Full Text] [Related]
3. Quantitative bone SPECT/CT: high specificity for identification of prostate cancer bone metastases.
Tabotta F; Jreige M; Schaefer N; Becce F; Prior JO; Nicod Lalonde M
BMC Musculoskelet Disord; 2019 Dec; 20(1):619. PubMed ID: 31878904
[TBL] [Abstract][Full Text] [Related]
4. Standardized uptake values of
Qi N; Meng Q; You Z; Chen H; Shou Y; Zhao J
BMC Med Imaging; 2021 Feb; 21(1):39. PubMed ID: 33639883
[TBL] [Abstract][Full Text] [Related]
5. Comparison of bone SUV obtained from different SPECT/CT systems.
Yoshimura M; Kugai N; Aida T; Hakamata D; Miyajima N; Takahashi Y
Hell J Nucl Med; 2023; 26(3):181-186. PubMed ID: 38085833
[TBL] [Abstract][Full Text] [Related]
6. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
7. Skeletal standardized uptake values obtained using quantitative SPECT/CT for the detection of bone metastases in patients with lung adenocarcinoma.
Lin L; Zheng R; Geng J; Wang X; Li M; Fan R; Zheng Y; Yang K
Front Med (Lausanne); 2023; 10():1119214. PubMed ID: 36817798
[TBL] [Abstract][Full Text] [Related]
8. Comparison of bone single-photon emission computed tomography (SPECT)/CT and bone scintigraphy in assessing knee joints.
An YS; Park DY; Min BH; Lee SJ; Yoon JK
BMC Med Imaging; 2021 Mar; 21(1):60. PubMed ID: 33771130
[TBL] [Abstract][Full Text] [Related]
9. Skeletal standardized uptake values obtained by quantitative SPECT/CT as an osteoblastic biomarker for the discrimination of active bone metastasis in prostate cancer.
Kuji I; Yamane T; Seto A; Yasumizu Y; Shirotake S; Oyama M
Eur J Hybrid Imaging; 2017; 1(1):2. PubMed ID: 29782587
[TBL] [Abstract][Full Text] [Related]
10. The diagnostic value of quantitative bone SPECT/CT in solitary undetermined bone lesions.
Du F; Wumener X; Zhang Y; Liu M; Li T; Huang S; Zhang M; Wu R; Liang Y
Front Oncol; 2023; 13():1205379. PubMed ID: 38023132
[TBL] [Abstract][Full Text] [Related]
11. Test-retest repeatability of quantitative bone SPECT/CT.
Yamane T; Fukushima K; Shirotake S; Nishimoto K; Okabe T; Oyama M; Seto A; Kuji I
Ann Nucl Med; 2021 Mar; 35(3):338-346. PubMed ID: 33400148
[TBL] [Abstract][Full Text] [Related]
12. Quantitative bone SPECT/CT applications for cartilaginous bone neoplasms.
Kitajima K; Futani H; Tsuchitani T; Takahashi Y; Tachibana T; Yamakado K
Hell J Nucl Med; 2020; 23(2):133-137. PubMed ID: 32716404
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity of intrahepatic fat distribution determined by (18)F-FDG PET and CT.
Keramida G; Hunter J; Dizdarevic S; Peters AM
Ann Nucl Med; 2016 Apr; 30(3):200-6. PubMed ID: 26768891
[TBL] [Abstract][Full Text] [Related]
14. Texture analysis on (18)F-FDG PET/CT images to differentiate malignant and benign bone and soft-tissue lesions.
Xu R; Kido S; Suga K; Hirano Y; Tachibana R; Muramatsu K; Chagawa K; Tanaka S
Ann Nucl Med; 2014 Nov; 28(9):926-35. PubMed ID: 25107363
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of quantitative bone SPECT/CT for bone metastasis diagnosis.
Ikeda T; Kitajima K; Tsuchitani T; Takahashi Y; Hama Y; Kotura N
Hell J Nucl Med; 2022; 25(3):253-259. PubMed ID: 36507881
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of bone metastasis burden as an imaging biomarker by quantitative single-photon emission computed tomography/computed tomography for assessing prostate cancer with bone metastasis: a phantom and clinical study.
Motegi K; Matsutomo N; Yamamoto T; Koizumi M
Radiol Phys Technol; 2020 Sep; 13(3):219-229. PubMed ID: 32535819
[TBL] [Abstract][Full Text] [Related]
17. The role of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiating between benign and malignant adrenal lesions.
Ozcan Kara P; Kara T; Kara Gedik G; Kara F; Sahin O; Ceylan Gunay E; Sari O
Nucl Med Commun; 2011 Feb; 32(2):106-12. PubMed ID: 21085046
[TBL] [Abstract][Full Text] [Related]
18. Differential diagnostic value of single-photon emission computed tomography/spiral computed tomography with Tc-99m-methylene diphosphonate in patients with spinal lesions.
Zhang Y; Shi H; Gu Y; Xiu Y; Li B; Zhu W; Chen S; Yu H
Nucl Med Commun; 2011 Dec; 32(12):1194-200. PubMed ID: 21934544
[TBL] [Abstract][Full Text] [Related]
19. The value of quantitative analysis in
Lapa P; Marques M; Costa G; Lima JP
Rev Esp Med Nucl Imagen Mol; 2017; 36(2):78-84. PubMed ID: 27793635
[TBL] [Abstract][Full Text] [Related]
20. Metabolic activity in bone metastases of breast and prostate cancer were similar as studied by
Pietrzak A; Czepczynski R; Wierzchoslawska E; Cholewinski W
Hell J Nucl Med; 2017; 20(3):237-240. PubMed ID: 29177262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
